Virtual Reality Food Marketing for Public Health
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how virtual reality (VR) marketing affects snack choices and feelings like hunger and excitement in young adults. Participants will experience either a VR food marketing scene (Wendyverse VR food marketing experience) or a non-food VR scene (Nikeland VR non-food marketing experience). The trial aims to determine if these virtual experiences influence snack preferences or purchasing decisions. It is ideal for young adults aged 18-24 who identify as Black or white, live in the NYC area, and do not have strong food dislikes or severe motion sickness. As an unphased trial, this study provides a unique opportunity to contribute to understanding the impact of VR marketing on consumer behavior.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this VR experience is safe for participants?
Research shows that specific safety information for the Wendyverse VR food marketing experience is not available. This new use of virtual reality focuses on promoting food. Since the trial does not involve a drug or medical device, typical concerns about side effects are less relevant. Instead, the main focus is on participants' reactions to the VR experience itself. Most people generally handle virtual reality well, though some might experience motion sickness or dizziness. Overall, available information suggests that using VR for food marketing does not present known safety risks. Those with concerns should consider discussing them with the trial coordinators.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how virtual reality (VR) can influence public health through food marketing. Unlike traditional marketing methods, these VR experiences immerse participants in interactive environments, potentially making the marketing more engaging and impactful. By comparing a non-food VR experience with a food-focused one, researchers aim to understand how different types of VR marketing might sway consumer behavior and choices. This could lead to innovative marketing strategies that promote healthier eating habits.
What evidence suggests that this trial's treatments could be effective?
Research shows that virtual reality (VR) food marketing can affect young adults' eating habits. Studies have found that VR-based food marketing, such as the Wendyverse, often increases cravings and snack consumption. This trial will compare the effects of the Wendyverse VR food marketing experience with the Nikeland VR non-food marketing experience. The Nikeland VR experience, which does not focus on food, serves as a control for comparison. Although VR technology is still evolving, early evidence highlights its strong influence on young adults' food-related behavior.12467
Who Is on the Research Team?
Omni Cassidy, Ph.D.
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for black and white young adults interested in how virtual reality (VR) affects snack consumption, purchase intentions, hunger, and arousal. Specific eligibility criteria are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
VR Exposure
Participants are exposed to either VR food marketing or VR non-food control for 15 minutes and provide feedback
Post-Exposure Assessment
Participants' purchase intention, salivary flow, electrodermal activity, and snack consumption are measured
Follow-up
Participants are monitored for any immediate reactions or feedback post-exposure
What Are the Treatments Tested in This Trial?
Interventions
- Nikeland VR non-food marketing experience
- Wendyverse VR food marketing experience
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator